D609-mediated inhibition of ATP synthesis in neural progenitor cells

Haviryaji S G Kalluri1, Robert J Dempsey

  • 1aDepartment of Neurological Surgery bCardiovascular Research Center, University of Wisconsin, Madison, Wisconsin, USA.

Neuroreport
|June 12, 2014
PubMed

Insights

Tricyclodecan-9-yl-xanthogenate (D609) reduces neural progenitor cell proliferation by inhibiting ATP synthesis. This molecule decreases cellular ATP content and cytochrome c oxidase activity, impacting energy production.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Tricyclodecan-9-yl-xanthogenate (D609) exhibits antioxidative, antiproliferative, and neuroprotective effects.
  • Previous studies indicated D609 reduces neural progenitor cell proliferation.

Purpose of the Study:

  • To investigate the antioxidative effects of D609 on rat neural progenitor cells.
  • To determine the impact of D609 on cellular ATP content and cytochrome c oxidase (Cox) activity.

Main Methods:

  • Neural progenitor cells were isolated from the subventricular zone of rat brains.
  • Cellular oxidation was assessed by measuring ATP content.
  • Cytochrome c oxidase (Cox) activity was measured after D609 incubation.

Main Results:

  • D609 decreased neural progenitor cell ATP content by approximately 40%.
  • D609 incubation led to a reduction in Cox activity.
  • These findings suggest D609 inhibits cellular metabolic activity and ATP synthesis.

Conclusions:

  • D609 inhibits cytochrome c oxidase (Cox) activity in neural progenitor cells.
  • D609 suppresses ATP synthesis, potentially explaining its antiproliferative effects.
  • D609's antioxidative properties may involve the regulation of cellular energy metabolism.